Table 2: Survival rates in HYPERO study. Adapted from [87].

Time-point HIPEC used n OS (m) 2 years % 5 years % Overall 141 30.3 49.1 25.4 Frontline 26 41.7 57.0 33.3 Interval debulking 19 68.6 80.4 50.2 Consolidation 12 53.7 63.6 42.4 Recurrence 83 23.5 40.9 18.0

OS: overall survival.